GDF15 and prostate cancer: The current study showed a differential level of MIC-1 both in circulation and in tumor tissues from prostate cancer patients of African American and Caucasian races and proposes circulatory MIC-1 as a biomarker to improve clinical sensitivity in the diagnosis of prostate cancer in African American men.